Why We Are Losing the War Against COVID-19 on the Data Front and How to Reverse the Situation
JMIRx Med · 2021
DOI: 10.2196/20617 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIRx Med, 2021. Verfasst von David Prieto-Merino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Epidemiology & Population Health London School of Hygiene & Tropical Medicine London United Kingdom. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
With over 117 million COVID-19–positive cases declared and the death count approaching 3 million, we would expect that the highly digitalized health systems of high-income countries would have collected, processed, and analyzed large quantities of clinical data from patients with COVID-19. Those data should have served to answer important clinical questions such as: what are the risk factors for becoming infected? What are good clinical variables to predict prognosis? What kinds of patients are more likely to survive mechanical ventilation? Are there clinical subphenotypes of the disease? All these, and many more, are crucial questions to improve our clinical strategies against the epidemic and save as many lives as possible. One might assume that in the era of big data and machine learning, there would be an army of scientists crunching petabytes of clinical data to answer these questions. However, nothing could be further from the truth. Our health systems have proven to be completely unprepared to generate, in a timely manner, a flow of clinical data that could feed these analyses. Despite gigabytes of data being generated every day, the vast quantity is locked in secure hospital data servers and is not being made available for analysis. Routinely collected clinical data are, by and large, regarded as a tool to inform decisions about individual patients, and not as a key resource to answer clinical questions through statistical analysis. The initiatives to extract COVID-19 clinical data are often promoted by private groups of individuals and not by health systems, and are uncoordinated and inefficient. The consequence is that we have more clinical data on COVID-19 than on any other epidemic in history, but we have failed to analyze this information quickly enough to make a difference. In this viewpoint, we expose this situation and suggest concrete ideas that health systems could implement to dynamically analyze their routine clinical data, becoming learning health systems and reversing the current situation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Epidemiology & Population Health London School of Hygiene & Tropical Medicine London United Kingdom.
- Applied Statistical Methods in Medical Research Group Catholic University of San Antonio in Murcia Murcia Spain.
- Institute of Health Informatics University College London London United Kingdom.
- University of Medical Sciences Havana Cuba.
ORCID-Profile: David Prieto-Merino, Rui Bebiano Da Providencia E Costa, Jorge Bacallao Gallestey, Reecha Sofat, Sheng-Chia Chung, Henry Potts
Zitieren
APA
Prieto-Merino, D., Bebiano Da Providencia E Costa, R., Bacallao Gallestey, J., Sofat, R., Chung, S. C., & Potts, H. (2021). Why We Are Losing the War Against COVID-19 on the Data Front and How to Reverse the Situation. JMIRx Med. https://doi.org/10.2196/20617
Vancouver
Prieto-Merino D, Bebiano Da Providencia E Costa R, Bacallao Gallestey J, Sofat R, Chung SC, Potts H. Why We Are Losing the War Against COVID-19 on the Data Front and How to Reverse the Situation. JMIRx Med. 2021. doi:10.2196/20617
BibTeX
@article{PrietoMerino2021,
author = {Prieto-Merino, David and Bebiano Da Providencia E Costa, Rui and Bacallao Gallestey, Jorge and Sofat, Reecha and Chung, Sheng-Chia and Potts, Henry},
title = {Why We Are Losing the War Against COVID-19 on the Data Front and How to Reverse the Situation},
journal = {JMIRx Med},
year = {2021},
doi = {10.2196/20617}
}
EUVIMED